Gabriella Pittau

Gabriella Pittau

Auto-generated profile, based on publicly available information

Gabriella Pittau

AP-HP, Hôpital Paul Brousse, Centre Hépato-Biliaire

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2020 in BMC Cancer
Verified
Journal Article
Open access
PDF file
AUAyhan Ulusakarya
Ayhan Ulusakarya
AKAbdoulaye Karaboué
Abdoulaye Karaboué
OCOriana Ciacio
Oriana Ciacio
GPGabriella Pittau
Gabriella Pittau
MHMazen Haydar
Mazen Haydar
Pasquale InnominatoPasquale Innominato
Pasquale Innominato
FOLFIRINOX is a pillar first-line regimen in the treatment of pancreatic cancer. Historically, biliary tract cancer (BTC) and pancreatic cancer have been treated similarly with gemcitabine alone or combined with a platinum compound. With growing evidence supporting the role of fluoropyrimidines in the treatment of BTC, we aimed at assessing the outcomes of patients (pts) with BTC on frontline FOLFIRINOX. We retrospectively analyzed data of all our consecutive patients with locally advanced (LA) or metastatic (M) BTC who were registered to receive FOLFIRINOX as a first-line therapy between 12/2013 and 11/2017 at Paul Brousse university hospital. The main endpoints were Overall Survival (OS), Time-to-Progression (TTP), best Objective Response Rate (ORR), Disease Control rate (DCR), secondary macroscopically-complete resection (res) and incidence of severe (grade 3–4) toxicity (tox). There were 17 male (40%) and 25 female (60%) pts. aged 36 to 84 years (median: 67). They had PS of 0 (55%) or 1 (45%), and intrahepatic cholangiocarcinoma (CCA) (21 pts., 50%), gallbladder carcinoma (8 pts., 19%), perihilar CCA (7 pts., 17%), distal CCA (4 pts., 10%) and ampulloma (2 pts., 5%). BTC was LA or M in 10 (24%) and 32 pts. (76%) respectively. Biliary stent was placed in 14 pts. (33%). A median of 10 courses was given with median treatment duration of 6 months. There were no untoward toxicity issues, with no febrile neutropenia, emergency admission for toxicity or toxic death. We observed 12 partial responses (29%) and 19 disease stabilisations (45%). Six patients (14%) underwent secondary R0-R1 resection. Median TTP was 8 months [95%CL, 6–10] and median OS was 15 months [13–17]. Patients undergoing secondary resection displayed a 3-y disease-free rate of 83%. First-line FOLFIRINOX offers promising results in patients with LA and M-BTC. It deserves prospective evaluation to further improve outcomes for advanced BTC.

1 April 2020 in Journal of Visceral Surgery
Verified
Journal Article
Closed access
ESEric Savier
Eric Savier
RBRaffaele Brustia
Raffaele Brustia
JGJ.-L. Golmard
J.-L. Golmard
OSO. Scatton
O. Scatton
AMA. Mallet
A. Mallet
BHB. Heyd
B. Heyd

1 October 2022 in Clinical Transplantation
Verified
Journal Article
Closed access
AMAlessandra Mazzola
Alessandra Mazzola
GPGabriella Pittau
Gabriella Pittau
SHSuk Kyun Hong
Suk Kyun Hong
SCSrinath Chinnakotla
Srinath Chinnakotla
HTHans‐Michael Tautenhahn
Hans‐Michael Tautenhahn
TGthe ERAS4OLT.org Working Group
the ERAS4OLT.org Working Group

8 May 2020 in Surgical Laparoscopy, Endoscopy & Percutaneous Techniques
Verified
Journal Article
Closed access
Benedetto IelpoBenedetto Ielpo
Benedetto Ielpo
DPDaniel Pietrasz
Daniel Pietrasz
LTLaia Torrent
Laia Torrent
PTPauline Tortajada
Pauline Tortajada
OCOriana Ciacio
Oriana Ciacio
ACAntonio Sa Cunha
Antonio Sa Cunha
Laparoscopic left pancreatectomy for pancreatic cancer has increased worldwide over the last decade. However, this procedure is technically challenging compared with traditional laparoscopic left pancreatectomy and still needs to be better standardized. On this video, we describe the standardization of the technique at our center, highlighting some technical tips and tricks.

1 November 2015 in Journal de Chirurgie Viscérale
Verified
Journal Article
Closed access
BRB. Le Roy
B. Le Roy
RMRiccardo Memeo
Riccardo Memeo
GPG. Pittau
G. Pittau
MGMaximiliano Gelli
Maximiliano Gelli
OCO. Ciacio
O. Ciacio
ACA. Sa Cunha
A. Sa Cunha

1 June 2021 in EMC - Técnicas Quirúrgicas - Aparato Digestivo
Verified
Journal Article
Closed access
NBN. Beghdadi
N. Beghdadi
MAM.-A. Allard
M.-A. Allard
GPG. Pittau
G. Pittau
IBI. Boytchev
I. Boytchev
ACA. Sa Cunha
A. Sa Cunha